These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 22858005)

  • 1. Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers.
    Solomon M; Pavlotzky F; Barzilai A; Schwartz E
    J Am Acad Dermatol; 2013 Feb; 68(2):284-9. PubMed ID: 22858005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.
    Solomon M; Baum S; Barzilai A; Scope A; Trau H; Schwartz E
    J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.
    Solomon M; Pavlotsky F; Leshem E; Ephros M; Trau H; Schwartz E
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):973-7. PubMed ID: 21129042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis.
    Brown M; Noursadeghi M; Boyle J; Davidson RN
    Br J Dermatol; 2005 Jul; 153(1):203-5. PubMed ID: 16029352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
    El-Sayed M; Anwar AE
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.
    Llanos-Cuentas A; Tulliano G; Araujo-Castillo R; Miranda-Verastegui C; Santamaria-Castrellon G; Ramirez L; Lazo M; De Doncker S; Boelaert M; Robays J; Dujardin JC; Arevalo J; Chappuis F
    Clin Infect Dis; 2008 Jan; 46(2):223-31. PubMed ID: 18171254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leishmania braziliensis: report of a pediatric imported case with response to liposomal amphotericin B].
    Campos-Muñoz L; Quesada-Cortés A; Martín-Díaz MA; Rubio-Flores C; de Lucas-Laguna R
    Actas Dermosifiliogr; 2007; 98(1):42-4. PubMed ID: 17374332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis.
    Soto J; Valda-Rodriquez L; Toledo J; Vera-Navarro L; Luz M; Monasterios-Torrico H; Vega J; Berman J
    Am J Trop Med Hyg; 2004 Nov; 71(5):577-81. PubMed ID: 15569787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of Liposomal-amphotericin B Treatment for New World Cutaneous Leishmaniasis due to Leishmania braziliensis.
    Kosaka A; Sakamoto N; Hikone M; Imai K; Ota M; Washino T; Maeda T; Iwabuchi S
    Intern Med; 2020; 59(9):1227-1230. PubMed ID: 32378656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.
    Soto J; Rea J; Balderrama M; Toledo J; Soto P; Valda L; Berman JD
    Am J Trop Med Hyg; 2008 Feb; 78(2):210-1. PubMed ID: 18256415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers.
    Eichner S; Thoma-Uszynski S; Herrgott I; Sebald H; Debus A; Tsianakas A; Ehrchen J; Harms G; Simon M; Sunderkötter C; Bogdan C
    Eur J Dermatol; 2013 Apr; 23(2):218-23. PubMed ID: 23557633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.
    Wortmann G; Miller RS; Oster C; Jackson J; Aronson N
    Clin Infect Dis; 2002 Aug; 35(3):261-7. PubMed ID: 12115091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
    Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
    Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of childhood cutaneous leishmaniasis with liposomal amphotericin B: report of two cases.
    del Rosal T; Artigao FB; Miguel MJ; de Lucas R; del Castillo F
    J Trop Pediatr; 2010 Apr; 56(2):122-4. PubMed ID: 19656844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia.
    Bermúdez H; Rojas E; Garcia L; Desjeux P; Dujardin JC; Boelaert M; Chappuis F
    Ann Trop Med Parasitol; 2006 Oct; 100(7):591-600. PubMed ID: 16989685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, controlled, comparative study on intralesional 10% and 15% hypertonic saline versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis.
    Ranawaka RR; Weerakoon HS; de Silva SH
    Int J Dermatol; 2015; 54(5):555-63. PubMed ID: 25600472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India.
    Bumb RA; Mehta RD; Ghiya BC; Jakhar R; Prasad N; Soni P; Lezama-Davila C; Satoskar AR
    Br J Dermatol; 2010 Oct; 163(4):854-8. PubMed ID: 20500797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial.
    Reithinger R; Mohsen M; Wahid M; Bismullah M; Quinnell RJ; Davies CR; Kolaczinski J; David JR
    Clin Infect Dis; 2005 Apr; 40(8):1148-55. PubMed ID: 15791515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.
    Soto J; Rojas E; Guzman M; Verduguez A; Nena W; Maldonado M; Cruz M; Gracia L; Villarroel D; Alavi I; Toledo J; Berman J
    Clin Infect Dis; 2013 May; 56(9):1255-60. PubMed ID: 23390069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.